Related Experiment Video
Updated: Jan 28, 2026

Zika Virus Specific Diagnostic Epitope Discovery
Published on: December 12, 2017
Strategies for Zika drug discovery
1Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
Abstract:
Zika virus (ZIKV) can cause devastating congenital syndrome in fetuses from pregnant women and autoimmune disorder Guillain-Barré syndrome in adults. No clinically approved vaccine or drug is currently available for ZIKV. This unmet medical need has motivated a global effort to develop countermeasures. Several promising ZIKV vaccine candidates have already entered clinical trials. In contrast, antiviral development of ZIKV is lagging behind. Here, we review the overall strategies for ZIKV drug discovery, including (i) repurposing of clinically approved drugs, (ii) viral replication-based phenotypic screening for inhibitors, and (iii) targeted drug discovery of viral proteins. Along with vaccines, the development of antiviral treatment will provide a complementary means to control ZIKV infections.
More Related Videos
10:16High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication
Published on: October 30, 2021
09:39Establishing Mouse Models for Zika Virus-induced Neurological Disorders Using Intracerebral Injection Strategies: Embryonic, Neonatal, and Adult
Published on: April 26, 2018
Related Concept Videos
Drug Discovery: Overview
Persuasion Strategies
Coping Strategies: Problem Focused
For example, consider a student who struggles to understand their...
Strategies of Self-Presentation II: Self-Verification
Pharmacokinetics: Drug–Drug Interactions
Coping Strategies: Emotion Focused